$829 Million is the total value of Hudson Executive Capital LP's 5 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 16.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DB | DEUTSCHE BANK A Gnamen akt | $707,330,355 | +3.4% | 67,389,676 | 0.0% | 85.35% | +4.7% | |
CTLP | CANTALOUPE INC | $97,477,046 | +39.6% | 12,245,860 | 0.0% | 11.76% | +41.3% | |
TALK | TALKSPACE INC | $12,440,412 | +82.7% | 11,340,600 | 0.0% | 1.50% | +84.9% | |
LSYN | Buy | LIBERATED SYNDICATION INC | $5,928,000 | -38.7% | 3,120,000 | +4.8% | 0.72% | -38.0% |
VRAY | VIEWRAY INC | $5,547,887 | -89.8% | 15,752,093 | 0.0% | 0.67% | -89.7% | |
AKYA | Exit | AKOYA BIOSCIENCES INC | $0 | – | -1,736,017 | -100.0% | -1.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
NATERA INC | 15 | Q4 2022 | 4.6% |
CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
VIEWRAY INC | 14 | Q2 2023 | 8.2% |
ATRICURE INC | 13 | Q3 2019 | 20.9% |
CIT GROUP INC | 11 | Q2 2018 | 26.4% |
TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-21 |
4 | 2024-02-21 |
SC 13D/A | 2024-02-21 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-07-21 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13D/A | 2023-02-07 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.